CFTR and cystic fibrosis: ENaC is thought to be aberrantly active in CF (11, 12), with evidence suggesting that this is attributable in part to CFTR dysfunction (13, 14), although the presence of hyperactive ENaC and the role of CFTR remain a matter of debate (15–17).